CA
LJPC

Cliff Asness’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Cliff Asness’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-23,081
Closed -$98K – 2337
2020
Q2 		$98K Buy
23,081
+9,006
+64% +$54.8K ﹤0.01% 2061
2020
Q1 		$59K Buy
+14,075
New +$88.9K ﹤0.01% 2001

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Cliff Asness's LJPC Position: Q3 2020 in Review

Cliff Asness sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2020, closing a stake of 23,081 shares — an estimated $98K sold.

Cliff Asness first reported a position in LJPC in Q1 2020 and held it in 2 quarters. The position peaked at $98K in Q2 2020. 64 funds tracked by Wall St. Rank hold LJPC as of Q3 2020.

  • Cliff Asness reported no remaining La Jolla Pharmaceutical Company position as of Q3 2020 after selling out during the quarter.
  • Cliff Asness sold 23,081 La Jolla Pharmaceutical Company shares in Q3 2020, an estimated $98K.
  • Cliff Asness first reported a position in La Jolla Pharmaceutical Company in Q1 2020 and held it in 2 quarters.
  • Cliff Asness's La Jolla Pharmaceutical Company position peaked at $98K in Q2 2020.
  • 64 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2020.

Based on AQR Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.